The estimated Net Worth of Keith R. Harris is at least $707 millier dollars as of 5 June 2024. Keith Harris owns over 30,000 units of MeiraGTx plc stock worth over $208,000 and over the last 5 years he sold MGTX stock worth over $0. In addition, he makes $498,716 as Independent Chairman of the Board at MeiraGTx plc.
Sign up
Keith Harris MGTX stock SEC Form 4 insiders trading
Keith has made over 2 trades of the MeiraGTx plc stock since 2023, according to the Form 4 filled with the SEC. Most recently he exercised 30,000 units of MGTX stock worth $124,800 on 5 June 2024.
The largest trade he's ever made was exercising 30,000 units of MeiraGTx plc stock on 5 June 2024 worth over $124,800. On average, Keith trades about 7,143 units every 52 days since 2019. As of 5 June 2024 he still owns at least 50,000 units of MeiraGTx plc stock.
You can see the complete history of Keith Harris stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Keith Harris biography
Dr. Keith R. Harris Ph.D. serves as Independent Chairman of the Board of the Company. He has served as a member of our Board of Directors since June 2015 and served as chairman of our Board of Directors since February 2018. Dr. Harris is a London-based investment banker and financier with a 25-year career as a senior corporate finance and takeover advisor. Since 1999, Dr. Harris has been the chairman of Keith Harris & Associates, a sports consulting firm. Dr. Harris previously served as Chief Executive Officer of HSBC Investment Bank from 1994 to 1999 and Seymour Pierce Holdings Limited, a subsidiary of which, Seymour Pierce Limited, was acquired in a pre-paid administration under United Kingdom (“U.K.”) law in 2013. Dr. Harris received a B.A. in business and economics from the University of Bradford and a Ph.D. in Economics from the University of Surrey.
What is the salary of Keith Harris?
As the Independent Chairman of the Board of MeiraGTx plc, the total compensation of Keith Harris at MeiraGTx plc is $498,716. There are 8 executives at MeiraGTx plc getting paid more, with Alexandria Forbes having the highest compensation of $8,480,260.
How old is Keith Harris?
Keith Harris is 66, he's been the Independent Chairman of the Board of MeiraGTx plc since 2018. There are 4 older and 13 younger executives at MeiraGTx plc. The oldest executive at MeiraGTx Holdings plc is Arnold Levine, 80, who is the Independent Director.
What's Keith Harris's mailing address?
Keith's mailing address filed with the SEC is 450 EAST 29TH STREET, 14TH FLOOR, NEW YORK, NY, 10016.
Insiders trading at MeiraGTx plc
Over the last 6 years, insiders at MeiraGTx plc have traded over $7,031,523 worth of MeiraGTx plc stock and bought 9,222,038 units worth $85,317,799 . The most active insiders traders include Advisors Llcperceptive Life..., Joel S Marcus et Life Sciences Master Fund L.... On average, MeiraGTx plc executives and independent directors trade stock every 33 days with the average trade being worth of $672,044. The most recent stock trade was executed by Advisors Llcperceptive Life... on 12 August 2024, trading 1,250,000 units of MGTX stock currently worth $5,000,000.
What does MeiraGTx plc do?
meiragtx, a london and new york-based gene therapy company, is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. we are pioneering the use of gene therapy to treat devastating neurodegenerative diseases such as alzheimer’s disease (ad), parkinson’s disease (pd), and amyotrophic lateral sclerosis (als). we are developing innovative gene therapies for ocular diseases including rare inherited blindness and age-related macular degeneration (amd). meiragtx is also establishing treatments for xerostomia, a frequent and debilitating side effect of radiation treatment used in head and neck cancers. our revolutionary gene regulation technologies promise to transform the way gene therapy can be applied and create new paradigms for biologic therapeutics.
What does MeiraGTx plc's logo look like?
Complete history of Keith Harris stock trades at vTv Therapeutics Inc et MeiraGTx plc
MeiraGTx plc executives and stock owners
MeiraGTx plc executives and other stock owners filed with the SEC include:
-
Alexandria Forbes,
President, Chief Executive Officer, Director -
Richard Giroux,
Chief Financial Officer, Chief Operating Officer -
Dr. Alexandria Forbes,
CEO, Pres & Director -
Martin Indyk,
Independent Director -
Richard Brian Giroux B.A.,
COO & CFO -
Stuart Naylor,
Chief Development Officer -
Dr. Stuart Naylor Ph.D.,
Chief Devel. Officer -
Nicole Seligman,
Independent Director -
Keith Harris,
Independent Chairman of the Board -
Neil Mendoza,
Independent Director -
Joel Marcus,
Independent Director -
Arnold Levine,
Independent Director -
Thomas Shenk,
Independent Director -
Ellen Hukkelhoven,
Independent Director -
Elizabeth Broder,
Investor Relations -
Dr. Robert K. Zeldin M.D.,
Chief Medical Officer -
Dr. Alastair Leighton,
Sr. VP of Manufacturing & Supply Chain -
Tim Randall,
Sr. VP of Risk & Internal Controls -
Joel P. Brooks,
Sr. VP of Fin. -
Christine Elise Sheehy,
Sr. VP of Global Integration -
Dr. Michel Michaelides M.D.,
Head of Clinical Ophthalmology -
Robert J. Wollin J.D.,
Gen. Counsel & Sec. -
& Johnson Innovation Jjdc...,
10% owner -
Advisors Llcperceptive Life...,
-
Katherine Breedis,
Chief Financial Officer -
Life Sciences Master Fund L...,
-
Bruce Gottlieb,
General Counsel -
Advisors Llcedelman Joseph ...,
-
Debra Yu,
-
Robert K Zeldin,
CHIEF MEDICAL OFFICER -
Robert J Wollin,
GENERAL COUNSEL AND SECRETARY